🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Global vaccine-sharing programme reaches milestone of 1 billion doses

Published 01/15/2022, 02:46 PM
Updated 01/15/2022, 02:50 PM
© Reuters. FILE PHOTO:  Biomedical engineers confirms a consignment of AstraZeneca/Oxford vaccines under the COVAX scheme against coronavirus disease (COVID-19), before distribution at the Kitengela cold rooms stores in Kitengela, outside Nairobi, Kenya March 4, 202

By Francesco Guarascio

BRUSSELS (Reuters) - The COVAX global vaccine-sharing programme has delivered 1 billion COVID-19 vaccine doses, one of the organisations which manages it said on Saturday.

Supplies to poorer nations have long been very limited because of lack of vaccines, as wealthier states secured most of the doses initially available from December 2020.

But in the last quarter shipments have exponentially increased, allowing COVAX to reach the milestone of 1 billion doses shipped to 144 countries, said Gavi, which co-leads the programme alongside the World Health Organization (WHO).

COVAX was launched in 2020 with the goal of delivering 2 billion doses by the end of 2021, but was slowed by wealthier states' initial hoarding of limited shots, export restrictions and frequent changes https://www.reuters.com/business/healthcare-pharmaceuticals/global-vaccines-project-revamp-rules-after-britain-got-more-than-botswana-2021-09-27 within its organisation.

The program began delivering vaccine doses in February 2021. About one-third have been donated by rich nations, despite COVAX's initial plans to supply only jabs procured directly by the programme with a budget of over $10 billion in donors' funds.

The change of strategy has led to delays, as donors have often requested to send doses to countries selected by them.

© Reuters. FILE PHOTO:  Biomedical engineers confirms a consignment of AstraZeneca/Oxford vaccines under the COVAX scheme against coronavirus disease (COVID-19), before distribution at the Kitengela cold rooms stores in Kitengela, outside Nairobi, Kenya March 4, 2021. REUTERS/Monicah Mwangi

Despite the recent surge in deliveries, vaccine inequity remains high. The latest WHO data shows 67% of the population in richer nations have been fully vaccinated, compared with only 5% in poorer nations. Over 40% of the world's population has not yet received a first dose.

Gavi, a vaccine alliance which co-manages COVAX, is seeking more funds to reach the WHO's goal of vaccinating 70% of the population in poorer nations by July.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.